GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Aristo Bio-Tech and Lifescience Ltd (NSE:ARISTO) » Definitions » Cash And Cash Equivalents

Aristo Bio-Tech and Lifescience (NSE:ARISTO) Cash And Cash Equivalents : ₹6 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aristo Bio-Tech and Lifescience Cash And Cash Equivalents?

Aristo Bio-Tech and Lifescience's quarterly cash and cash equivalents declined from Mar. 2023 (₹18.33 Mil) to Sep. 2023 (₹7.29 Mil) but then stayed the same from Sep. 2023 (₹7.29 Mil) to Mar. 2024 (₹6.12 Mil).

Aristo Bio-Tech and Lifescience's annual cash and cash equivalents increased from Mar. 2022 (₹4.16 Mil) to Mar. 2023 (₹18.33 Mil) but then declined from Mar. 2023 (₹18.33 Mil) to Mar. 2024 (₹6.12 Mil).


Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Historical Data

The historical data trend for Aristo Bio-Tech and Lifescience's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Cash And Cash Equivalents
5.25 1.12 4.16 18.33 6.12

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial 4.16 13.08 18.33 7.29 6.12

Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Aristo Bio-Tech and Lifescience  (NSE:ARISTO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Aristo Bio-Tech and Lifescience's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Aristo Bio-Tech and Lifescience Business Description

Traded in Other Exchanges
N/A
Address
E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.

Aristo Bio-Tech and Lifescience Headlines

No Headlines